Fetal anomalies: Ethical and legal considerations in screening, detection, and management

Clinics in Perinatology

Volumn 30, Issue 1, 2003, Pages 113-126

  Strong, Carson ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTION; AMNIOCENTESIS; ANENCEPHALUS; BENEFICENCE; BRAIN HERNIA; CESAREAN SECTION; CHORION VILLUS SAMPLING; CLINICAL PRACTICE; COGNITION; COURT; DECISION MAKING; DEPRESSION; DISEASE ASSOCIATION; DOCTOR PATIENT RELATION; DOWN SYNDROME; EMOTIONAL STRESS; FETUS; FETUS DEVELOPMENT; FETUS DISTRESS; FETUS MALFORMATION; FOLLOW UP; GENETIC PROCEDURES; GESTATIONAL AGE; GRIEF; HIGH RISK POPULATION; HUMAN; HYDROCEPHALUS; INFORMED CONSENT; LABOR INDUCTION; LEGAL ASPECT; MATERNAL WELFARE; MEDICAL ETHICS; PALLIATIVE THERAPY; PATIENT COUNSELING; PERINATAL DEATH; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SUPPORT GROUP; SURVIVAL; TREATMENT INDICATION; VAGINAL DELIVERY;

EID: 0037347698     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-5108(02)00083-0     Document Type: Review

References (40)

1. Berman v Allen, 80 NJ 421, 404 A 2d 8 (1979).
2. Park v Chessin, 413 NYS 2d 895, 386 NE 2d 809 (1978).
3. Gath A. The impact of an abnormal child upon the parents. Br J Psychiatry 1977;130:405-10.
4. Holroyd J, Guthrie D. Stress in families of children with neuromuscular disease. J Clin Psychol 1979;35:734-9.
5. Romans-Clarkson SE, Clarkson JE, Dittmer ID, et al. Impact of a handicapped child on mental health of parents. Br Med J (Clin Res Ed) 1986;293:1395-7.
6. Roach MA, Orsmond GI, Barratt MS. Mothers and fathers of children with Down syndrome: parental stress and involvement in childcare. Am J Ment Retard 1999;104:422-36.
7. Weinans MJ, Huijssoon AM, Tymstra T, et al. How women deal with the results of serum screening for Down syndrome in the second trimester of pregnancy. Prenat Diagn 2000;20:705-8.
8. Tercyak KP, Johnson SB, Roberts SF, et al. Psychological response to prenatal genetic counseling and amniocentesis. Patient Educ Couns 2001;43:73-84.
9. Côté-Arsenault D, Bidlack D, Humm A. Women's emotions and concerns during pregnancy following perinatal loss. MCN Am J Matern Child Nurs 2001;26:128-34.
10. Cederholm M, Sjoden PO, Axelsson O. Psychological distress before and after prenatal invasive karyotyping. Acta Obstet Gynecol Scand 2001;80:539-45.
11. Sklansky M, Tang A, Levy D, et al. Maternal psychological impact of fetal echocardiography. J Am Soc Echocardiogr 2002;15:159-66.
12. Cain J, Stacy L, Jusenius K, et al. The quality of dying: financial, psychological, and ethical dilemmas. Obstet Gynecol 1990;76:149-52.
13. Buckman R. How to break bad news: a guide for health care professionals. Baltimore: The Johns Hopkins University Press; 1992.
14. Creagan ET. How to break bad news-and not devastate the patient. Mayo Clin Proc 1994;69:1015-7.
15. Chisholm CA, Pappas DJ, Sharp MC. Communicating bad news. Obstet Gynecol 1997;90:637-9.
16. Hammond I, Franche RL, Black DM, et al. The radiologist and the patient: breaking bad news. Can Assoc Radiol J 1999;50:233-4.
17. Strong C. Ethics in reproductive and perinatal medicine: a new framework. New Haven: Yale University Press; 1997.
18. Strong C. An ethical framework for managing fetal anomalies in the third trimester. Clin Obstet Gynecol 1992;35:792-802.
19. Chervenak FA, McCullough LB. An ethically justified, clinically comprehensive management strategy for third-trimester pregnancies complicated by fetal anomalies. Obstet Gynecol 1990; 75:311-6.
20. Linton PB. Enforcement of state abortion statutes after Roe: a state-by-state analysis. University of Detroit Law Review 1990;67:157-259.
21. Manchester D, Clewell W, Manco-Johnson M, et al. Management of pregnancies with suspected fetal anomalies: clinical experience and ethical issues. In: Nimrod C, Griener G, editors. Biomedical ethics and fetal therapy. Waterloo (Ontario): Wilfred Laurier University Press; 1988. p. 67-79.
22. Chervenak FA, McCullough LB. Does obstetric ethics have any role in the obstetrician's response to the abortion controversy? Am J Obstet Gynecol 1990;163:1425-9.
23. Bryar SH. One day your pregnant and one day you're not: pregnancy interruption for fetal anomalies. J Obstet Gynecol Neonatal Nurs 1997;26:559-66.
24. Dallaire L, Lortie G, Des Rochers M, et al. Parental reaction and adaptability to the prenatal diagnosis of fetal defect or genetic disease leading to pregnancy interruption. Prenat Diagn 1995; 15:249-59.
25. Bourguinon A, Briscoe B, Nemzer L. Genetic abortion: considerations for patient care. J Perinat Neonat Nurs 1999;13:47-58.
26. Roe v Wade, 410 US 113 (1973).
27. Colautti v Franklin, 439 US 379 (1979).
28. Planned Parenthood of Missouri v Danforth, 428 US 52 (1976).
29. Peabody JL, Emery JR, Ashwal S. Experience with anencephalic infants as prospective organ donors. N Engl J Med 1989;321:344-50.
30. McAbee G, Sherman J, Canas JA, et al. Prolonged survival of two anencephalic infants. Am J Perinatol 1993;10:175-7.
31. Annas GJ. Asking the courts to set the standard of emergency care: the case of Baby K. N Engl J Med 1994;330:1542-5.
32. Jones KL. Smith's recognizable patterns of human malformation, 4th edition. Philadelphia: WB Saunders; 1988.
33. Date I, Yagyu Y, Asari S, et al. Long-term outcome in surgically treated encephalocele. Surg Neurol 1993;40:125-30.
34. Martinez-Lage JF, Poza M, Sola J, et al. The child with a cephalocele: etiology, neuroimaging, and outcome. Childs Nerv Syst 1996;12:540-50.
35. Spinnato JA, Cook VD, Cook CR, et al. Aggressive intrapartum management of lethal fetal anomalies: beyond fetal beneficence. Obstet Gynecol 1995;85:89-92.
36. Hoeldtke NJ, Calhoun BC. Perinatal hospice. Am J Obstet Gynecol 2001;185:525-9.
37. Wallerstedt C, Higgins P. Facilitating prinatal grieving between the mother and the father. J Obstet Gynecol Neonatal Nurs 1996;25:389-94.
38. Haddow JE, Bradley LA, Palomaki GE, et al. Issues in implementing prenatal screening for cystic fibrosis: results of a working conference. Genet Med 1999;1:129-35.
39. Strong C. Tomorrow's prenatal genetic testing: should we test for "minor" diseases? Arch Fam Med 1993;2:1187-93.
40. Lancaster JM, Wiseman RW, Berchuck A. An inevitable dilemma: prenatal testing for mutations in the BRCA1 breast-ovarian cancer susceptibility gene. Obstet Gynecol 1996;87:306-9.